Uterine carcinosarcomas: A case series of 9 cases from a low-income country
Open Access
- 4 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (40) , e39773
Abstract
Rationale: Uterine carcinosarcomas (UCS) are rare aggressive biphasic tumors classified as a subtype of high-grade uterine carcinomas. However, these tumors have particular histopathological features and clinical behavior with worse prognosis than high-grade uterine carcinomas. Patient concerns: The incidence of UCS is increasing and more studies are required to elucidate their clinical and histopathological characteristics. Herein, we report clinicopathological features of 9 cases of UCS in a low-income country. Diagnoses: We retrospectively collected all cases of UCS at our Pathology Department over a period of 4 years. The diagnosis was performed on formalin-fixed, paraffin-embedded and hematoxylin and eosin–stained surgical specimens. Interventions: Nine surgically treated cases of UCS have been registered, representing 12.67% of all uterine malignancies with a mean age of 58.88 years (range: 50–65 years). Abdominal pain and metrorrhagia were the main clinical presentations. The epithelial component of UCS was often a serous carcinoma (66.66%) and patients presented with large tumors (mean size of 9.24 cm, range of 5–19 cm), with advanced FIGO stages (stages III–IV) in 5/9 patients (55.55%). Outcomes: Follow-up data were available in 5/9 patients among which only 2 were alive 2 and 25 months after the surgical treatment (overall survival of 40%). Lessons: UCS are rare and aggressive uterine tumors with very poor prognosis especially in low-income countries.Keywords
This publication has 16 references indexed in Scilit:
- High-grade endometrial carcinomas: Morphologic spectrum and molecular classificationSeminars in Diagnostic Pathology, 2022
- Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics studyGynecologic Oncology Reports, 2022
- Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta‐analysis of survivalInternational Journal of Gynecology & Obstetrics, 2021
- Uterine carcinosarcomas: From pathology to practiceGynecologic Oncology, 2021
- TCGA Classification of Endometrial Cancer: the Place of CarcinosarcomaPathology and Oncology Research, 2020
- Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical CharacteristicsInternational Journal of Gynecological Pathology, 2017
- FIGO staging for carcinoma of the vulva, cervix, and corpus uteriInternational Journal of Gynecology & Obstetrics, 2014
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Pathologic and molecular features of uterine carcinosarcomasSeminars in Diagnostic Pathology, 2010
- Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?Journal of Clinical Pathology, 2002